Home » Topics » BioWorld Science

BioWorld Science
RSS

University of Pittsburgh research reveals GGTI-298, a new geranylgeranyltransferase-1 inhibitor

May 31, 1996

Cell signaling inhibitor, CTC-119, antitumor activity reported

May 31, 1996

Merck & Co. reveals protein farnesyltransferase-inhibiting analogues

May 31, 1996

More protein farnesyltransferase inhibitors from Warner-Lambert

May 31, 1996

MuIGIF with interferon gamma production-stimulating properties identified

May 31, 1996

Results of MAb-B1 phase I/II trial announced

May 31, 1996

IMMU-14 demonstrates evidence of activity

May 31, 1996

Approval to initiate NOVOMAb-G2 phase I studies granted by the FDA

May 31, 1996

Encouraging results of IDEC-C2B8 trial reported

May 31, 1996

Multikine trial commenced

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...